(Q41047260)

26 September 2017

title

Plasma Concentration of Endogenous Tissue Plasminogen Activator and the Occurrence of Future Cardiovascular Events (English)

1 reference

26 September 2017

Ridker PM

1

1 reference

26 September 2017

publication date

1 January 1994

1 reference

Journal of Thrombosis and Thrombolysis

26 September 2017

published in

1 reference

26 September 2017

volume

1

1 reference

26 September 2017

issue

1

1 reference

26 September 2017

page(s)

35-40

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01061993

26 September 2017

exact match

0 references

cites work

Circadian variation of acute myocardial infarction and the effect of low-dose aspirin in a randomized trial of physicians

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01061993

Blood platelet count and function are related to total and cardiovascular death in apparently healthy men

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01061993

Direct effects of gemfibrozil on the fibrinolytic system. Diminution of synthesis of plasminogen activator inhibitor type 1

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01061993

Ethyl alcohol enhances plasminogen activator secretion by endothelial cells

21 January 2018

1 reference

12 December 2020

Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction

1 reference

12 December 2020

Evidence for increased levels of plasminogen activator inhibitor and tissue plasminogen activator in plasma of patients with angiographically verified coronary artery disease

1 reference

12 December 2020

Plasminogen activator inhibitor-1 levels in patients with chronic angina pectoris with or without angiographic evidence of coronary sclerosis

1 reference

12 December 2020

Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease

1 reference

12 December 2020

Endogenous tissue-type plasminogen activator and risk of myocardial infarction

1 reference

12 December 2020

Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries

1 reference

12 December 2020

Increased fibrinolytic activity in the intima of atheromatous coronary arteries: protection at a price

1 reference

12 December 2020

Influence of platelet size on outcome after myocardial infarction

1 reference

12 December 2020

Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study

1 reference

12 December 2020

Interrelationships between plasma levels of plasminogen activator inhibitor, tissue plasminogen activator, lipoprotein (a), and established cardiovascular risk factors in a north Swedish population

1 reference

12 December 2020

Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction

1 reference

12 December 2020

Fibrinogen as a risk factor for stroke and myocardial infarction

1 reference

12 December 2020

Augmentation of synthesis of plasminogen activator inhibitor type 1 by insulin and insulin-like growth factor type I: implications for vascular disease in hyperinsulinemic states

1 reference

12 December 2020

Plasma tissue plasminogen activator levels in patients with coronary heart disease.

1 reference

12 December 2020

Prospective study of endogenous tissue plasminogen activator and risk of stroke

1 reference

12 December 2020

Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function

1 reference

12 December 2020

Relationships between euglobulin clot lysis time and the plasma levels of tissue plasminogen activator and plasminogen activator inhibitor 1

1 reference

12 December 2020

Bleeding diathesis due to decreased functional activity of type 1 plasminogen activator inhibitor

1 reference

12 December 2020

Circadian variation in the frequency of onset of acute myocardial infarction

1 reference

12 December 2020

Fatty streaks and fibrous plaques in human aorta show increased plasminogen activator activity

1 reference

12 December 2020

Age dependence of tissue plasminogen activator concentrations in plasma, as studied by an improved enzyme-linked immunosorbent assay

1 reference

12 December 2020

Haemostatic variables and menopausal status: influence of hormone replacement therapy

1 reference

12 December 2020

Plasminogen activator inhibitors

1 reference

12 December 2020

Fibrinogen and risk of cardiovascular disease. The Framingham Study.

1 reference

12 December 2020

Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1)

1 reference

12 December 2020

Plasminogen activator inhibitor in the blood of patients with coronary artery disease

1 reference

12 December 2020

Plasminogen activator and plasminogen activator inhibitor activities in men with coronary artery disease

1 reference

12 December 2020

Baseline fibrinolytic state and the risk of future venous thrombosis. A prospective study of endogenous tissue-type plasminogen activator and plasminogen activator inhibitor

1 reference

12 December 2020

ECAT angina pectoris study: baseline associations of haemostatic factors with extent of coronary arteriosclerosis and other coronary risk factors in 3000 patients with angina pectoris undergoing coronary angiography

1 reference

12 December 2020

Circadian variation of tissue plasminogen activator and its inhibitor, von Willebrand factor antigen, and prostacyclin stimulating factor in men with ischaemic heart disease.

1 reference

12 December 2020

Circadian Variation of Fibrinolytic Activity in Blood

1 reference

12 December 2020

A cross-sectional study of endogenous tissue plasminogen activator, total cholesterol, HDL cholesterol, and apolipoproteins A-I, A-II, and B-100

1 reference

12 December 2020

Final report on the aspirin component of the ongoing Physicians' Health Study

1 reference

12 December 2020

Platelet hyperreactivity and prognosis in survivors of myocardial infarction

1 reference

12 December 2020

Hemostatic risk factors for coronary heart disease

1 reference

12 December 2020

Plasma fibrinogen--a major coronary risk factor

1 reference

12 December 2020

Enhancement of plasminogen activator activity in the gastric wall after chronic ethanol consumption

1 reference

12 December 2020

Effects of moderate alcohol consumption on platelet function, tissue-type plasminogen activator and plasminogen activator inhibitor.

1 reference

12 December 2020

Development of venous occlusions in mice transgenic for the plasminogen activator inhibitor-1 gene

1 reference

12 December 2020

Antigens of tissue plasminogen activator and plasminogen activator inhibitor 1: correlates in nonsmoking Japanese and Caucasian men and women

1 reference

12 December 2020

Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease

1 reference

12 December 2020

Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study

1 reference

12 December 2020

Urokinase-like plasminogen activator increased in plasma after alcohol drinking

1 reference

12 December 2020

Relationship between smoking and fibrinolytic system with special reference to t-PA and PA inhibitor

1 reference

12 December 2020

Predictive value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease. A 7-year follow-up

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01061993

1 reference

26 September 2017

1 reference